Variable | Healthcare staff | Information and education | Psychological problem | Physical symptom | Social support | Hospital service | Religious support | Total |
---|---|---|---|---|---|---|---|---|
Age (years) | ||||||||
< 40 | 1.29 ± 1.04a | 1.48 ± 1.00 | 1.21 ± 1.11a | 0.91 ± 0.93ab | 0.72 ± 0.74 | 1.32 ± 1.17a | 0.65 ± 1.00 | 1.06 ± 0.84 |
40 ~ 49 | 1.53 ± 0.99ab | 1.74 ± 0.95 | 1.39 ± 0.94a | 1.13 ± 0.86bc | 0.82 ± 0.72 | 1.62 ± 0.99b | 0.96 ± 1.13 | 1.26 ± 0.76 |
50 ~ 59 | 1.69 ± 0.97b | 1.78 ± 0.84 | 1.47 ± 0.96b | 1.28 ± 0.85c | 0.96 ± 0.79 | 1.66 ± 1.04b | 0.98 ± 1.16 | 1.37 ± 0.72 |
≥ 60 | 1.28 ± 0.94a | 1.53 ± 0.85 | 1.06 ± 0.81a | 0.80 ± 0.69a | 0.70 ± 0.69 | 1.17 ± 0.97a | 0.83 ± 1.13 | 1.04 ± 0.61 |
p-value | 0.042 | 0.170 | 0.096 | 0.008 | 0.155 | 0.030 | 0.361 | 0.030 |
Menopausal status | ||||||||
Premenopause | 1.53 ± 1.00 | 1.72 ± 0.93 | 1.35 ± 0.97 | 1.09 ± 0.86 | 0.80 ± 0.70 | 1.57 ± 1.03 | 0.90 ± 1.13 | 1.24 ± 0.75 |
Postmenopause | 1.54 ± 0.98 | 1.67 ± 0.87 | 1.37 ± 0.96 | 1.16 ± 0.87 | 0.93 ± 0.82 | 1.50 ± 1.05 | 0.94 ± 1.12 | 1.27 ± 0.75 |
p-value | 0.930 | 0.648 | 0.866 | 0.519 | 0.144 | 0.519 | 0.794 | 0.652 |
Time since diagnosis (years) | ||||||||
≤ 1 | 1.56 ± 1.02 | 1.85 ± 0.85 | 1.56 ± 0.97 | 1.28 ± 0.96 | 0.93 ± 0.83 | 1.63 ± 1.07 | 0.99 ± 1.19 | 1.35 ± 0.79 |
> 1, ≤ 3 | 1.52 ± 0.99 | 1.71 ± 0.90 | 1.35 ± 0.96 | 1.09 ± 0.85 | 0.86 ± 0.72 | 1.63 ± 1.00 | 0.97 ± 1.11 | 1.27 ± 0.75 |
> 3, ≤ 5 | 1.40 ± 0.95 | 1.54 ± 0.95 | 1.18 ± 0.94 | 0.99 ± 0.79 | 0.70 ± 0.71 | 1.39 ± 1.05 | 0.73 ± 1.07 | 1.09 ± 0.68 |
> 5 | 1.59 ± 0.97 | 1.53 ± 0.94 | 1.26 ± 0.97 | 1.13 ± 0.82 | 0.79 ± 0.74 | 1.22 ± 1.03 | 0.77 ± 1.07 | 1.22 ± 0.76 |
p-value | 0.782 | 0.172 | 0.143 | 0.252 | 0.324 | 0.121 | 0.418 | 0.235 |
Family history of breast cancer | ||||||||
No | 1.55 ± 0.98 | 1.72 ± 0.90 | 1.37 ± 0.97 | 1.13 ± 0.86 | 0.85 ± 0.75 | 1.59 ± 1.04 | 0.94 ± 1.13 | 1.27 ± 0.74 |
Yes | 1.27 ± 1.05 | 1.45 ± 0.94 | 1.24 ± 0.96 | 1.00 ± 0.93 | 0.77 ± 0.80 | 1.01 ± 0.97 | 0.58 ± 0.99 | 1.08 ± 0.83 |
p-value | 0.151 | 0.138 | 0.486 | 0.451 | 0.567 | 0.006 | 0.111 | 0.209 |
Operation method of breast | ||||||||
BCS | 1.49 ± 0.99 | 1.67 ± 0.89 | 1.30 ± 0.96 | 1.06 ± 0.86 | 0.81 ± 0.73 | 1.50 ± 1.03 | 0.84 ± 1.10 | 1.24 ± 0.76 |
Mastectomy | 1.58 ± 0.94 | 1.77 ± 0.90 | 1.49 ± 0.96 | 1.21 ± 0.86 | 0.92 ± 0.78 | 1.69 ± 1.03 | 1.14 ± 1.19 | 1.41 ± 0.73 |
(NA)SSM | 1.46 ± 1.05 | 1.55 ± 1.09 | 1.38 ± 1.00 | 1.25 ± 0.84 | 0.81 ± 0.71 | 1.43 ± 1.11 | 0.74 ± 1.01 | 1.23 ± 0.81 |
p-value | 0.752 | 0.579 | 0.344 | 0.296 | 0.556 | 0.325 | 0.111 | 0.253 |
Operation method of axilla | ||||||||
SLNB | 1.48 ± 1.03 | 1.65 ± 0.93 | 1.32 ± 0.98 | 1.08 ± 0.85 | 0.84 ± 0.78 | 1.49 ± 1.04 | 0.94 ± 1.14 | 1.26 ± 0.78 |
ALND | 1.57 ± 0.91 | 1.75 ± 0.85 | 1.41 ± 0.94 | 1.19 ± 0.88 | 0.84 ± 0.68 | 1.64 ± 1.02 | 0.85 ± 1.08 | 1.33 ± 0.72 |
p-value | 0.430 | 0.308 | 0.444 | 0.265 | 0.954 | 0.218 | 0.486 | 0.453 |
TNM stage | ||||||||
0 | 1.31 ± 0.90 | 1.36 ± 0.82 | 1.01 ± 0.97a | 0.96 ± 0.91 | 0.49 ± 0.53a | 1.08 ± 0.85a | 0.42 ± 0.67 | 0.93 ± 0.61 |
I | 1.44 ± 1.02 | 1.60 ± 0.97 | 1.21 ± 0.94ab | 0.95 ± 0.78 | 0.69 ± 0.67ab | 1.40 ± 1.01ab | 0.90 ± 1.13 | 1.14 ± 0.74 |
II | 1.60 ± 0.99 | 1.77 ± 0.83 | 1.44 ± 0.96ab | 1.22 ± 0.88 | 0.96 ± 0.77b | 1.64 ± 1.06b | 0.95 ± 1.14 | 1.32 ± 0.74 |
III & IV | 1.63 ± 0.94 | 1.82 ± 0.96 | 1.62 ± 0.97b | 1.31 ± 0.96 | 1.00 ± 0.85b | 1.79 ± 1.04b | 1.00 ± 1.15 | 1.42 ± 0.79 |
p-value | 0.438 | 0.187 | 0.030 | 0.025 | 0.004 | 0.036 | 0.435 | 0.034 |
Multiplicity | ||||||||
No | 1.46 ± 0.98 | 1.66 ± 0.89 | 1.31 ± 0.95 | 1.07 ± 0.84 | 0.81 ± 0.73 | 1.50 ± 1.04 | 0.84 ± 1.08 | 1.20 ± 0.73 |
Yes | 1.82 ± 0.97 | 1.86 ± 0.97 | 1.57 ± 1.01 | 1.33 ± 0.93 | 0.99 ± 0.82 | 1.74 ± 1.03 | 1.25 ± 1.26 | 1.48 ± 0.80 |
p-value | 0.011 | 0.117 | 0.054 | 0.035 | 0.088 | 0.099 | 0.011 | 0.007 |
Estrogen receptor | ||||||||
Negative | 1.44 ± 0.96 | 1.63 ± 0.93 | 1.38 ± 0.99 | 1.16 ± 0.87 | 0.92 ± 0.80 | 1.47 ± 1.10 | 0.96 ± 1.16 | 1.25 ± 0.76 |
Positive | 1.56 ± 1.00 | 1.72 ± 0.90 | 1.35 ± 0.96 | 1.11 ± 0.86 | 0.83 ± 0.74 | 1.57 ± 1.02 | 0.92 ± 1.12 | 1.25 ± 0.75 |
p-value | 0.360 | 0.476 | 0.854 | 0.697 | 0.371 | 0.477 | 0.804 | 0.978 |
Progesterone receptor | ||||||||
Negative | 1.50 ± 0.94 | 1.71 ± 0.88 | 1.44 ± 0.95 | 1.22 ± 0.84 | 0.92 ± 0.78 | 1.52 ± 1.04 | 1.03 ± 1.18 | 1.31 ± 0.75 |
Positive | 1.55 ± 1.01 | 1.70 ± 0.92 | 1.33 ± 0.97 | 1.08 ± 0.87 | 0.83 ± 0.74 | 1.56 ± 1.04 | 0.88 ± 1.11 | 1.23 ± 0.75 |
p-value | 0.696 | 0.959 | 0.346 | 0.199 | 0.291 | 0.773 | 0.277 | 0.426 |
HER2 | ||||||||
Negative | 1.48 ± 0.99 | 1.64 ± 0.93 | 1.29 ± 0.96 | 1.07 ± 0.86 | 0.77 ± 0.70 | 1.46 ± 1.03 | 0.86 ± 1.14 | 1.19 ± 0.74 |
Positive | 1.63 ± 0.98 | 1.84 ± 0.83 | 1.52 ± 0.95 | 1.22 ± 0.86 | 1.01 ± 0.84 | 1.73 ± 1.05 | 1.03 ± 0.10 | 1.38 ± 0.74 |
p-value | 0.214 | 0.059 | 0.505 | 0.139 | 0.015 | 0.035 | 0.220 | 0.039 |
Chemotherapy | ||||||||
No | 1.49 ± 1.03 | 1.53 ± 0.91 | 1.26 ± 1.00 | 0.97 ± 0.81 | 0.75 ± 0.74 | 1.43 ± 1.02 | 1.05 ± 1.15 | 1.21 ± 0.76 |
Yes | 1.52 ± 0.97 | 1.74 ± 0.90 | 1.39 ± 0.95 | 1.16 ± 0.88 | 0.87 ± 0.74 | 1.58 ± 1.04 | 0.86 ± 1.10 | 1.31 ± 0.76 |
p-value | 0.821 | 0.071 | 0.298 | 0.099 | 0.238 | 0.283 | 0.183 | 0.349 |
Hormonal therapy | ||||||||
No | 1.53 ± 0.98 | 1.70 ± 0.92 | 1.40 ± 0.99 | 1.21 ± 0.92 | 0.90 ± 0.80 | 1.52 ± 1.12 | 0.85 ± 1.09 | 1.31 ± 0.78 |
Yes | 1.50 ± 0.99 | 1.69 ± 0.90 | 1.34 ± 0.95 | 1.07 ± 0.84 | 0.81 ± 0.72 | 1.55 ± 1.00 | 0.93 ± 1.13 | 1.28 ± 0.75 |
p-value | 0.801 | 0.938 | 0.624 | 0.201 | 0.320 | 0.858 | 0.585 | 0.753 |
Radiation therapy | ||||||||
No | 1.45 ± 0.93 | 1.69 ± 0.89 | 1.50 ± 0.92 | 1.16 ± 0.86 | 0.92 ± 0.78 | 1.52 ± 1.08 | 1.02 ± 1.15 | 1.32 ± 0.75 |
Yes | 1.52 ± 1.00 | 1.69 ± 0.91 | 1.31 ± 0.97 | 1.10 ± 0.86 | 0.81 ± 0.73 | 1.54 ± 1.02 | 0.87 ± 1.11 | 1.27 ± 0.76 |
p-value | 0.601 | 0.999 | 0.168 | 0.582 | 0.322 | 0.880 | 0.361 | 0.630 |
Target therapy | ||||||||
No | 1.48 ± 0.99 | 1.66 ± 0.92 | 1.30 ± 0.97 | 1.06 ± 0.86 | 0.78 ± 0.72 | 1.48 ± 1.03 | 0.87 ± 1.12 | 1.24 ± 0.75 |
Yes | 1.59 ± 0.99 | 1.81 ± 0.83 | 1.53 ± 0.91 | 1.29 ± 0.86 | 1.03 ± 0.81 | 1.77 ± 1.04 | 1.03 ± 1.12 | 1.44 ± 0.77 |
p-value | 0.462 | 0.189 | 0.085 | 0.056 | 0.016 | 0.050 | 0.312 | 0.063 |
Co-morbidity | ||||||||
No | 1.46 ± 0.94 | 1.78 ± 0.83 | 1.40 ± 0.94 | 1.19 ± 0.85 | 0.86 ± 0.73 | 1.52 ± 1.00 | 0.99 ± 1.17 | 1.28 ± 0.73 |
Yes | 1.52 ± 1.00 | 1.66 ± 0.93 | 1.34 ± 0.97 | 1.07 ± 0.86 | 0.82 ± 0.73 | 1.54 ± 1.04 | 0.91 ± 1.12 | 1.22 ± 0.75 |
p-value | 0.679 | 0.327 | 0.635 | 0.332 | 0.651 | 0.908 | 0.626 | 0.563 |
Adjuvant treatment | ||||||||
During | 1.50 ± 1.01 | 1.81 ± 0.88 | 1.43 ± 0.98ab | 1.21 ± 0.91ab | 0.94 ± 0.77b | 1.60 ± 1.08 | 0.99 ± 1.16 | 1.32 ± 0.77a |
After | 1.47 ± 0.96 | 1.58 ± 0.91 | 1.20 ± 0.91a | 0.98 ± 0.76a | 0.69 ± 0.67a | 1.46 ± 1.00 | 0.81 ± 1.09 | 1.13 ± 0.68ab |
Othersa | 1.77 ± 0.97 | 1.75 ± 0.97 | 1.67 ± 1.01b | 1.27 ± 0.98b | 1.01 ± 0.81b | 1.62 ± 1.04 | 1.06 ± 1.13 | 1.43 ± 0.83b |
p-value | 0.165 | 0.103 | 0.009 | 0.039 | 0.005 | 0.471 | 0.260 | 0.022 |